TIGIT and colorectal carcinoma: This analysis identified TIGIT–NECTIN-2 and TIGIT–PVR as dominant inhibitory ligand–receptor axes connecting CD8+ Tex cells with both stromal and malignant compartments within the CRC TME (23, 25).